Lenvatinib-d5 is the deuterium labeled Lenvatinib. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities[1][2].
Molecular Weight:
431.88
Formula:
C21H14D5ClN4O4
Target:
c-Kit,FGFR,PDGFR,RET,VEGFR
Application Notes:
Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
